Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:43:08 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Q:RSLS - RESHAPE LIFESCIENCES INC - https://www.reshapelifesciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RSLS - Q1.50.1715·0.20510.10.1762+0.00583.46,374.01,0602,6740.19  0.2299  0.17142.76  0.141419:40:20May 1515 min RT 2¢

Recent Trades - Last 10 of 2674
Time ETExPriceChangeVolume
19:40:20Q0.1780.00761,000
19:33:23Q0.18040.011
18:55:13Q0.18170.01131
18:50:55Q0.17310.00271,500
18:28:06Q0.17310.0027700
18:26:21Q0.1750.00466,000
18:20:13Q0.1750.00461,000
18:20:05Q0.1750.00461,000
18:00:49Q0.17310.00271
17:56:25Q0.17310.0027186

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-15 16:05U:RSLSNews ReleaseReShape Lifesciences(TM) Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
2024-05-14 08:31U:RSLSNews ReleaseReShape Lifesciences(TM) to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
2024-04-01 16:05U:RSLSNews ReleaseReShape Lifesciences(TM) Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
2024-03-28 08:31U:RSLSNews ReleaseReShape Lifesciences(TM) Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
2024-03-04 08:31U:RSLSNews ReleaseReShape Lifesciences(TM) Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band(TM) 2.0 FLEX
2024-02-22 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Announces First Surgeries Utilizing Next-Generation ‚  Lap-Band ‚ ® 2.0 FLEX
2024-01-24 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Conducts Bariatric Fellows Training for its Lap-Band ‚ ® System, Highlighting the Next-Generation Lap-Band ‚ ® 2.0 FLEX
2023-12-21 07:01U:RSLSNews ReleaseReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex
2023-12-20 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
2023-12-12 16:05U:RSLSNews ReleaseReShape Lifesciences ‚ ® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band ‚ ® 2.0 FLEX
2023-11-21 08:06U:RSLSNews ReleaseReShape Lifesciences ‚ ® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
2023-11-08 16:05U:RSLSNews ReleaseReShape Lifesciences ‚ ® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
2023-11-06 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
2023-09-29 12:30U:RSLSNews ReleaseReShape Lifesciences ‚ ® Announces Pricing of $3.0 Million Public Offering
2023-09-22 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Announces Participation in the LD Micro Main Event XVI
2023-09-21 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Signs Exclusive License Agreement With Biorad Medisys for Obalon ‚ ® Gastric Balloon System
2023-09-19 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Significantly Strengthens Patent Portfolio Related to its Obalon ‚ ® Balloon System
2023-09-14 08:31U:RSLSNews ReleaseReShape Lifesciences ‚ ® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation ¢ „ ¢ Device
2023-08-07 16:05U:RSLSNews ReleaseReShape Lifesciences ‚ ® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update
2023-08-03 16:05U:RSLSNews ReleaseReShape Lifesciences ‚ ® to Announce Financial Results for the Second Quarter Ended ‚  June 30, 2023 and Provide Corporate Update